T80.3XXD ABO incompatibility reaction, subsequent encounter

Name of the Condition

• ABO incompatibility reaction, subsequent encounter.

Summary

This condition represents a subsequent encounter for an adverse immune reaction resulting from ABO incompatibility, typically following a transfusion of blood or blood products. It is a serious complication that can lead to hemolysis, organ dysfunction, and systemic effects. The reaction occurs when pre-existing antibodies in the recipient target antigens on transfused red blood cells, triggering an immune response. This code is used for encounters after the initial reaction has been treated and the patient is receiving follow-up care.

Causes

ABO incompatibility reactions are caused by the transfusion of blood or blood products that do not match the recipient's ABO blood type. This mismatch leads to the destruction of transfused red blood cells by the recipient's antibodies, resulting in hemolysis. Errors in blood typing, crossmatching, or administration can contribute to this complication. The subsequent encounter code applies when the patient is being seen for ongoing management or complications related to the initial reaction.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain
• Renal dysfunction or oliguria

Diagnosis

Diagnosis involves reviewing the patient's transfusion history, clinical presentation, and laboratory results. Key tests include direct antiglobulin testing (Coombs test), blood typing, and crossmatching to confirm ABO incompatibility. Urinalysis may show hemoglobinuria, and bilirubin levels may be elevated. Imaging or other tests may be used to assess organ damage, such as renal function or liver involvement. The subsequent encounter code is appropriate when the patient is being evaluated for residual effects or complications from the initial reaction.

Treatment Options

Treatment focuses on managing symptoms and preventing further complications. This may include supportive care, such as fluid resuscitation, monitoring vital signs, and addressing renal or hepatic dysfunction. In severe cases, dialysis or other interventions may be necessary. The subsequent encounter code is used when the patient is receiving ongoing care related to the reaction, such as follow-up testing or management of chronic effects.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial reaction and the timeliness of treatment. Most patients recover with appropriate management, but severe cases can lead to long-term organ damage. Follow-up care may include monitoring for delayed complications, such as renal impairment or transfusion-related acute lung injury (TRALI). Regular laboratory tests and clinical assessments are typically recommended to ensure recovery.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Transfusion-related acute lung injury (TRALI)
• Sepsis or systemic inflammatory response syndrome (SIRS)
• Chronic organ dysfunction (e.g., liver or kidney)

Lifestyle & Prevention

Prevention is critical and involves strict adherence to blood typing and crossmatching protocols before transfusion. Double-checking blood product labels and patient identification can reduce errors. Patients with a history of ABO incompatibility should have their blood type clearly documented in medical records. Avoiding unnecessary transfusions and using leukoreduced products may also lower risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, dark urine, or difficulty breathing occur after a transfusion. These may indicate a recurrent or worsening reaction. Follow-up care is necessary for persistent symptoms or signs of organ dysfunction, even if initial treatment was successful.

Tips for Medical Coders

This code (T80.3XXD) is used for a subsequent encounter related to an ABO incompatibility reaction. Document the encounter as a follow-up visit for the reaction, including details of the initial event, current symptoms, and any ongoing management. Ensure the encounter is distinct from the initial reaction and that the patient is not receiving active treatment for the acute phase. Use this code only when the encounter is for care related to the reaction after the acute phase has resolved.